Author

Mark R. Schwartz

University of Virginia

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Research Focus:perturbation response prediction· 1

Frequent Co-Authors

David R. BreniniD· 1 shared Jonathan R. LindneriD· 1 shared Lydia E. KitelingeriD· 1 shared Matthew R. DeWittiD· 1 shared Nareen Z. Anwar· 1 shared Patrick Michael DilloniD· 1 shared Richard J. PriceiD· 1 shared Timothy N. J. BullockiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

David R. BreninORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

VEGFR2 blockade converts thermally ablative focused ultrasound into a potent driver of T cell-dependent anti-tumor immunity

Mark R. Schwartz, Nareen Z. Anwar, Lydia E. Kitelinger, David R. Brenin, Patrick Michael Dillon, Jonathan R. Lindner, Timothy N. J. Bullock, Matthew R. DeWitt, Richard J. Price

This study combines thermally ablative focused ultrasound with VEGFR2 blockade to enhance T cell-dependent anti-tumor immunity and synergize with checkpoint inhibition.

bioRxiv · Oct 23, 2025 · PreprintCancer Biology